Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5 366.8
7 424.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Apollo Hospitals Enterprise Ltd
Apollo Hospitals Enterprise Ltd
Cash & Cash Equivalents
Apollo Hospitals Enterprise Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Cash & Cash Equivalents
₹5.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
|
Cash & Cash Equivalents
₹468.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Cash & Cash Equivalents
₹6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
9%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Cash & Cash Equivalents
₹13.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
160%
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Cash & Cash Equivalents
₹4.7B
|
CAGR 3-Years
46%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Cash & Cash Equivalents
₹7.7B
|
CAGR 3-Years
123%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Apollo Hospitals Enterprise Ltd
Glance View
In the rapidly evolving landscape of healthcare, Apollo Hospitals Enterprise Ltd. stands out as a beacon of excellence and innovation. Founded in 1983 by Dr. Prathap C. Reddy, Apollo has transformed from a single hospital in Chennai, India, into one of the largest integrated healthcare providers in Asia and a trusted name globally. The company operates a vast network of over 70 hospitals, more than 350 clinics, and numerous pharmacy outlets, creating a seamless connection between various facets of health services that cater to a diverse population. As the healthcare needs of millions grow, Apollo leverages advanced technology, strategic partnerships, and a commitment to quality, positioning itself at the forefront of the industry. With a focus on multi-specialty care, trauma, and critical medical services, Apollo embodies the aspiration to enhance health outcomes and improve patient experiences. Investors looking at Apollo Hospitals may find the company’s robust growth and consistent financial performance particularly appealing. The organization has consistently reported strong revenue growth, supported by rising demand for healthcare services, an aging population, and an increase in lifestyle-related illnesses in India. Apollo’s commitment to diversification is evident in its investments in telehealth, digital services, and international expansion, which not only enhances its patient reach but also solidifies its role in shaping the future of healthcare. Furthermore, Apollo’s focus on quality, underscored by numerous national and international accreditations, assures investors of its dedication to maintaining high standards. As the healthcare sector continues to evolve and expand, Apollo Hospitals stands poised to capture significant market share, making it a compelling choice for investors seeking long-term growth in a resilient and essential industry.
See Also
What is Apollo Hospitals Enterprise Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
5.1B
INR
Based on the financial report for Mar 31, 2024, Apollo Hospitals Enterprise Ltd's Cash & Cash Equivalents amounts to 5.1B INR.
What is Apollo Hospitals Enterprise Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
12%
Over the last year, the Cash & Cash Equivalents growth was 17%. The average annual Cash & Cash Equivalents growth rates for Apollo Hospitals Enterprise Ltd have been 6% over the past three years , 12% over the past five years .
You don't have any saved screeners yet
